Study of BMS-986158 in Subjects With Select Advanced Cancers
Status:
Active, not recruiting
Trial end date:
2021-08-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability, pharmacokinetics, and
pharmacodynamics of BMS-986158 in subjects with select advanced cancers